Actavis has commenced with distribution of Zolpidem Tartrate Extended-Release Tablets in a 12.5mg strength.
Generics News
Teva has launched the generic version of Femara (letrozole; Novartis), an antineoplastic agent indicated for the treatment of breast cancer.
The FDA approved B. Braun Medical Inc.’s application for 1g and 2g Ceftazidime for Inj and Dextrose Inj in the DUPLEX Drug Delivery System, a ready-to-use two-compartment, IV container that stores pre-measured drug and diluent doses.
- Loading...
Want to read more?
Please login or register first to view this content.
